Validation of a Homogenous Mobility Shift Assay (HSMA) for the Measurement of Golimumab (GLM) and Antibodies to Golimumab (ATG) in Inflammatory Bowel Disease (IBD) Patient Serum: 1794
2013
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI